Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/30/2021
NMPA Issues the 14th Five Year Plan for National Drug Safety and Promo...
12/30/2021
Drug R&D and Product Registration News Digest December 2021 (2)
12/30/2021
Financial-related Company News Digest (December 2021)
12/30/2021
Recent Executive Moves
12/29/2021
Memorial Sloan Kettering and the Chinese Thoracic Oncology Group Discu...
12/29/2021
CDE Issues the Guidelines for Clinical Research of Late Term Colorecta...
12/29/2021
CDE Issues the Technical Guidelines for Expansion Cohorts in First-In-...
12/29/2021
CDE Issues the Technical Guidelines for Clinical Single- And Multiple-...
12/29/2021
18 Promising Novel Drugs Expected to Be Approved in China 2022
12/29/2021
Top Ten Chinese Biopharma In-licensing Deals in 2021
12/29/2021
Data Review – Chinese Oncology New Drug R&D Landscape
12/29/2021
China-Only Studies Are ‘Problematic,’ US FDA’s Pazdur Says Ahead of...
12/28/2021
NHC Issues the Guidelines for Clinical Application of New Anticancer D...
12/28/2021
SMEI Forecasts Outlook of Chinese Pharma in 2022
12/27/2021
China Issues Five Year Plan on Occupational Disease Prevention and Tre...
12/27/2021
NMPA Announces Rx Switch of OTC Dextromethorphan Hydrobromide Oral Sin...
12/27/2021
China Revises the Law on Progress of Science and Technology to Emphasi...
12/27/2021
ITM and Grand Pharma Enter Licensing Deal for Targeted Radiopharmaceut...
12/27/2021
Kintor Reports Unsatisfactory Interim Analysis on COVID-19 Pill Trial
12/27/2021
Norway Wealth Fund to divest from Yunnan Baiyao over Pangolins
12/27/2021
CStone's Precision Therapy AYVAKIT® (avapritinib) for GIST Approved i...
12/27/2021
China's 2021 Negative Lists Widen Market Access for Foreign Investment...
12/24/2021
Cosunter Pharma Partners with WuXi AppTec to Co-develop New Covid Dru...
12/24/2021
Drug R&D and Product Registration News Digest December 2021 (1)
12/23/2021
Luye Grants Genscience Chinese Commercialization Rights of Rivastigmin...
12/23/2021
BeiGene Launches Innovation Center in Guangzhou
12/23/2021
TOT Enters Co-promotion Deal with Jiangxi Jimin Kexin for Its Bevaciz...
12/23/2021
Sanofi Secures Additional Indication for Multaq (Dronedarone) in China
12/23/2021
Pfizer Gains Chinese Approval of ADC Drug Besponsa
12/21/2021
CDE Seeks Comments on Draft Chinese Translation of ICH Guideline ICH M...
Page:
99
/
719
Total number of articles:
21546
:
[First]
[<<]
[97]
[98]
[99]
[100]
[101]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit